Policy Submissions Policy Submissions PolicyStrategic Agreement 2022-2027 Health Technology Assessment (HTA) Access to Medicines Working Group (AMWG) Clinical TrialsClinical Trial Research Agreements Indemnity & Compensation Guidelines Research & Development Taskforce (RDTF) Tele-Trials Oncology Industry TaskforceAddressing the challenges of access to new cancer medications About the OIT Reports and resources Pharma Australia Inclusion Group (PAIG) Policy Submissions Regenerative Medicines Consortium Programme 2022 2021 2020 2019 2018 2017 2016 2022 Submission to PBAC Discount Rate Submission Monday, 21 February 2022 Medicines Australia Pre-Budget Submission 2022-2023 Friday, 28 January 2022
